At A Forum for Improving Drug Safety, a recent blog post excerpts an email sent by Genelex CEO Howard Coleman to people interested in promoting warfarin testing. The Center for Medicare and Medicaid Services has begun a study on whether the test should be covered by insurance and is accepting public comment until tomorrow.